Biocon shares surge 5% after USFDA classifies Bengaluru site as VAI

Biocon Share Price: Biocon shares surged 5.4% after FDA classified its Bengaluru facility as Voluntary Action Indicated (VAI). The stock is up 47.7% YoY, supported by strong technical indicators. Biocon Share Price: Biocon shares surged 5.4% after FDA classified its Bengaluru facility as Voluntary Action Indicated (VAI). The stock is up 47.7% YoY, supported by strong technical indicators.  Economic Times